Cystic fibrosis: Does it matter to avoid crushing Elexacaftor/Tezacaftor/Ivacaftor (ETI) tablets?

Pediatr Pulmonol. 2023 Dec;58(12):3603-3604. doi: 10.1002/ppul.26682. Epub 2023 Sep 13.
No abstract available

Keywords: Elexacaftor; crushing tablets; cystic fibrosis.

MeSH terms

  • Aminophenols / therapeutic use
  • Benzodioxoles / therapeutic use
  • Chloride Channel Agonists / therapeutic use
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / genetics
  • Humans
  • Mutation
  • Pyrazoles

Substances

  • ivacaftor
  • tezacaftor
  • elexacaftor
  • Aminophenols
  • Benzodioxoles
  • Pyrazoles
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Chloride Channel Agonists

Grants and funding